Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Quoin Pharmaceuticals Initiates Pediatric Clinical Study For Peeling Skin Syndrome In New Zealand

Author: Benzinga Newsdesk | August 06, 2024 05:03am
  • Peeling Skin Syndrome is a rare autosomal disease with no approved treatment or cure
  • Initial clinical site and pediatric patient identified in New Zealand
  • Company actively evaluating opening additional clinical sites in other countries

Posted In: QNRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist